DEF 14A Filing

Company

Protalix BioTherapeutics, Inc.

Filed

May 21, 2012

Period of Report

June 17, 2012

Accession Number

0001144204-12-030772

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →